2023-08-02T00:00:00.000+10:00
Ongoing

Ariceum

Ariceum
Lung cancer

A multicentre, open-label, phase Ia/Ib study investigating the safety, tolerability and efficacy of 177Lu-SSO110 with companion imaging 68Ga-SSO120 in participants with extensive stage Small Cell Lung Cancer who are on maintenance treatment with Atezolizumab (Ariceum SSO110-01)

A multicentre, open-label, phase Ia/Ib study investigating the safety, tolerability and efficacy of 177Lu-SSO110 with companion imaging 68Ga-SSO120 in participants with extensive stage Small Cell Lung Cancer who are on maintenance treatment with Atezolizumab (Ariceum SSO110-01)

Trial overview

Topic

Lung cancer

Trial registration

 

Number: ACTRN12623000185662

Study details

This study aims to assess the safety and tolerability of two new drugs in patients with extensive stage small cell lung cancer (ES SCLC). The first drug (68Ga-SSO120/68Ga-Satoreotide Trizoxetan) is used as a tumour imaging agent for patients who have tumours with specific receptors, while the second drug (177Lu-SSO110) targets and damages cancer cells with these specific receptors.

Further information

For more information regarding this clinical trial click here.

Location

GenesisCare Murdoch – PI: A/Prof. Joe Cardaci

GenesisCare Murdoch – PI: A/Prof. Joe Cardaci :::

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.